Introduction
============

The infusion of esmolol (a hypelective β~1~-blocker) is associated with immunomodulatory effects \[[@B1]\].

Methods
=======

Eighty white rabbits underwent pyelonephritis (multidrug-resistant *Pseudomonas aeruginosa*) induction and classification in pretreatment (PT) (*n*= 40) (infusion of esmolol immediately after pyelonephritis induction) and treatment (T) (*n*= 40) (initial infusion of esmolol 2 hours after pyelonephritis induction) group. PT = group A (*n*= 10, control, N/S 0.9% infusion), group B (*n*= 10, esmolol infusion), group C (*n*= 10, amikacin infusion) and group D (*n*= 10, esmolol and amikacin infusion) and T = groups E, F, G and H having similar treatment. Serum malondialdehyde (MDA) was estimated at serial time intervals by the thiobarbiturate assay followed by HPLC analysis. The animals were under survival follow-up every 12 hours for the next 21 days. After death, quantitative organ cultures were performed.

Results
=======

Median (IQR) MDA at 24 hours was 1.95 (0.75), 0.78 (1.79), 1.55 (1.60) and 0.12 (0.24) μmol/ml in groups A, B, C and D, respectively. Respective values at 48 hours were 2.60 (2.00), 1.40 (2.36), 3.15 (3.00) and 0.25 (0.20) μmol/ml. At 24 hours, the median (IQR) MDA of groups E, F, G and H were 2.80 (5.74), 0.32 (0.87), 0.61 (5.83) and 0.19 (2.75) μmol/ml, respectively. Tissue bacterial load was similar within groups. See Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.
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Conclusion
==========

In the present septic model, esmolol prolonged survival probably by exerting an immunomodulatory effect as assessed by reduced oxidative stress without any effect on tissue bacterial load.
